Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 3, 2004, Pages 538-547

  DeVoti, James A ^a   Steinberg, Bettie M ^a   Rosenthal, David W ^a   Hatam, Lynda ^a   Vambutas, Andrea ^a   Abramson, Allan L ^a   Shikowitz, Mark J ^a   Bonagura, Vincent R ^a,b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; PROTEIN E6; PROTEIN E7; VIRUS PROTEIN;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; LARYNX PAPILLOMATOSIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRUS INFECTION; WART VIRUS;

ADULT; ANTIGENS, CD3; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE PRODUCTS, TAT; HUMANS; IMMUNOBLOTTING; IMMUNOMAGNETIC SEPARATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-18; INTERLEUKIN-2; INTERLEUKINS; LARYNGEAL NEOPLASMS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 2442649101     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.3.538-547.2004     Document Type: Article

References (58)

1. Abramson, A. L., M. J. Shikowitz, V. M. Mullooly, B. M. Steinberg, C. A. Amella, and H. R. Rothstein. 1992. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 118:25-29.
2. Abramson, A. L., B. M. Steinberg, and B. Winkler. 1987. Laryngeal papillomatosis: clinical, histopathologic, and molecular studies. Laryngoscope 97:678-685.
3. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
4. Armstrong, L. R., E. J. Preston, M. Reichert, D. L. Phillips, R. Nisenbaum, N. W. Todd, I. N. Jacobs, A. F. Inglis, S. C. Manning, and W. C. Reeves. 2000. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin. Infect. Dis. 31:107-109.
5. - T lymphocytes: antigenic and functional properties. J. Immunol. 150:1147-1159.
6. Banchereau, J., S. Paczesny, P. Blanco, L. Bennett, V. Pascual, J. Fay, and A. K. Palucka. 2003. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann. N. Y. Acad. Sci. 987:180-187.
7. Bloom, B. R., R. L. Modlin, and P. Salgame. 1992. Stigma variations: observations on suppressor T cells and leprosy. Annu. Rev. Immunol. 10:453-488.
8. H2 cytokine imbalance. Clin. Immunol. 93:302-311.
9. Bonagura, V. R., F. P. Siegal, A. L. Abramson, F. Santiago-Schwarz, M. E. O'Reilly, K. Shah, D. Drake, and B. M. Steinberg. 1994. Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin. Diagn. Lab. Immunol. 1:357-360.
10. Broker, T. R., G. Jin, A. Croom-Rivers, S. M. Bragg, M. Richardson, L. T. Chow, S. H. Vermund, R. D. Alvarez, P. G. Pappas, K. E. Squires, and C. J. Hoesley. 2001. Viral latency: the papillomavirus model. Dev. Biol. 106:443-475.
11. + progenitors. J. Leukoc. Biol. 66:781-791.
12. Cerwenka, A., L. L. Carter, J. B. Reome, S. L. Swain, and R. W. Dutton. 1998. In vivo persistence of CD8 polarized T-cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161:97-105.
13. Cho, Y. S., J. W. Kang, M. Cho, C. W. Cho, S. Lee, Y. K. Choe, Y. Kim, I. Choi, S. N. Park, S. Kim, C. A. Dinarello, and D. Y. Yoon. 2001. Down-modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett. 501:139-145.
14. Chou, Q., M. Russell, D. E. Birch, J. Raymond, and W. Bloch. 1992. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res. 20:1717-1723.
15. Dartmann, K., E. Schwarz, L. Gissmann, and H. zur Hausen. 1986. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology 151:124-130.
16. + but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696.
17. de Saint-Vis, B., I. Fugier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervliet, S. Ait-Yahia, J. Banchereau, Y. J. Liu, S. Lebecque, and C. Caux. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160:1666-1676.
18. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567-4575.
19. Gelder, C. M., O. M. Williams, K. W. Hart, S. Wall, G. Williams, D. Ingrams, P. Bull, M. Bunce, K. Welsh, S. E. Marshall, and L. Borysiewicz. 2003. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J. Virol. 77:1927-1939.
20. Gissmann, L., V. Diehl, H. J. Schultz-Coulon, and H. zur Hausen. 1982. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J. Virol. 44:393-400.
21. Gissmann, L., L. Wolnik, H. Ikenberg, U. Koldovsky, H. G. Schnurch, and H. zur Hausen. 1983. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. USA 80:560-563.
22. + T and NK cells. J. Exp. Med. 180:1937-1942.
23. Heeney, J. L., M. E. van Gils, P. van der Meide, C. de Giuli Morghen, C. Ghioni, M. Gimelli, A. Raddelli, D. Davis, L. Akerblom, and B. Morein. 1998. The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. J. Med. Primatol. 27:50-58.
24. Holinger, P. H., K. C. Johnson, and G. C. Anison. 1950. Papilloma of larynx: review of 109 cases with preliminary report of aureomycin therapy. Ann. Otol. Rhinol. Laryngol. 59:547-563.
25. Kashima, H. B., B. Leventhal, and P. Mounts. 1985. Papilloma Study Group scoring system to assess severity and course in recurrent respiratory papillomatosis, p. 1-25. In H. Howley and T. Booker (ed.), Papillomavirus: molecular and clinical aspects. Alan R. Liss, New York, N.Y.
26. Kemp, R. A., and F. Ronchese. 2001. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J. Immunol. 167:6497-6502.
27. Li, L., S. Sad, D. Kagi, and T. R. Mosmann. 1997. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J. Immunol. 158:4152-4161.
28. + T cells. J. Immunol. 158:1551-1558.
29. Maran, A., C. A. Amella, T. P. Di Lorenzo, K. J. Auborn, L. B. Taichman, and B. M. Steinberg. 1995. Human papillomavirus type 11 transcripts are present at low abundance in latently infected respiratory tissues. Virology 212:285-294.
30. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
31. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199-205.
32. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol. Today 17:138-146.
33. Mounts, P., K. V. Shah, and H. Kashima. 1982. Viral etiology of juvenile-and adult-onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA 79:5425-5429.
34. Kip1 induces cell migration. Nat. Med. 4:1449-1452.
35. + seropositive juvenile rheumatoid arthritis. J. Exp. Med. 164:345-350.
36. Nishimura, Y., N. Kamikawaji, K. Fujisawa, H. Yoshizumi, M. Yasunami, A. Kimura, and T. Sasazuki. 1991. Genetic control of immune response and disease susceptibility by the HLA-DQ gene. Res. Immunol. 142:459-466.
37. Nuebtern, J. G., W. E. Biddison, and R. D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343:74-76.
38. Pitti, R. M., S. A. Marsters, D. A. Lawrence, M. Roy, F. C. Kischkel, P. Dowd, A. Huang, C. J. Donahue, S. W. Sherwood, D. T. Baldwin, P. J. Godowski, W. I. Wood, A. L. Gurney, K. J. Hillan, R. L. Cohen, A. D. Goddard, D. Botstein, and A. Ashkenazi. 1998. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699-703.
39. Romagnani, S. 1996. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 80:225-235.
40. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458.
41. + T cells is receptor dependent and HLA-DQ restricted. Proc. Natl. Acad. Sci. USA 88:2598-2602.
42. + cytotoxic T lymphocytes. J. Virol. 74:4729-4737.
43. Schwarze, S. R., A. Ho, A. Vocero-Akbani, and S. F. Dowdy. 1999. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572.
44. Scott, M., M. Nakagawa, and A. B. Moscicki. 2001. Cell-mediated immune response to human papillomavirus infection. Clin. Diagn. Lab. Immunol. 8:209-220.
45. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723-2730.
46. Sheu, B. C., R. H. Lin, H. C. Lien, H. N. Ho, S. M. Hsu, and S. C. Huang. 2001. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J. Immunol. 167:2972-2978.
47. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
48. Steinberg, B. M., T. Gallagher, M. Stoler, and A. L. Abramson. 1988. Persistence and expression of human papillomavirus during interferon therapy. Arch. Otolaryngol. Head Neck Surg. 114:27-32.
49. Stoll, S., H. Jonuleit, E. Schmitt, G. Muller, H. Yamauchi, M. Kurimoto, J. Knop, and A. H. Enk. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28:3231-3239.
50. Tazi, A., J. Moreau, A. Bergeron, S. Dominique, A. J. Hance, and P. Soler. 1999. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J. Immunol. 163:3511-3515.
51. Vambutas, A., V. R. Bonagura, E. F. Reed, A. L. Abramson, V. M. Mullooly, J. DeVoti, D. W. Gjertson, and B. M. Steinberg. Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11. J. Infect. Dis. 189:871-879.
52. Vambutas, A., J. DeVoti, W. Pinn, B. M. Steinberg, and V. R. Bonagura. 2001. Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin. Immunol. 101:94-99.
53. Vives, E., P. Brodin, and B. Lebleu. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:16010-16017.
54. Weiss, M. D., and H. K. Kashima. 1983. Tracheal involvement in laryngeal papillomatosis. Laryngoscope 93:45-48.
55. Welters, M. J., A. de Jong, S. J. van den Eeden, J. M. van der Hulst, K. M. Kwappenberg, S. Hassane, K. L. Franken, J. W. Drijfhout, G. J. Fleuren, G. Kenter, C. J. Melief, R. Offringa, and S. H. van der Burg. 2003. Frequent display of human papillomavirus type 16 E6-specific memory t-helper cells in the healthy population as witness of previous viral encounter. Cancer Res. 63:636-641.
56. + T cells secreting type 2 lymphokines are defective in protection against viral infection. Cell. Immunol. 202:13-22.
57. Yoshimoto, T., K. Takeda, T. Tanaka, K. Ohkusu, S. Kashiwamura, H. Okamura, S. Akira, and K. Nakanishi. 1998. IL-12 upregulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161:3400-3407.
58. Zwerschke, W., S. Joswig, and P. Jansen-Durr. 1996. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene 12:213-220.